CD47 and cancer: Optimize physicochemical properties (size, shape, charge); Surface modification: PEGylation; Self‐peptide (CD47) functionalization; Biomimetic membrane coating (e.g., RBC, leukocytes, platelets, macrophage, cancer cells).